Trident 690-10-22FRecalls & reported problems

Summary

The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 07613327024357), received between Jun 21, 2021 and Feb 26, 2024 — classified as 3 injuries.

The most frequently reported specific device problem is “Device Dislodged or Dislocated” (3 reports).

1 FDA recall record name this device's identifier, 1 still open.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Recalls naming this device

1. Jul 30, 2026Open, Classified

   Affected devices were manufactured with Ultra High Molecular Weight Polyethylene (UHMWPE) raw material aged in excess of five years. Product has the potential for elevated levels of oxidation, which may result in increased wear, leading to hazards such as excessive wear debris, material fragments, fractured device, or disassociated device. Potential harms include revision surgery, pain, and inflammation.

   Z-3201-2026 · Root cause: Process change control · Recall details · FDA record ↗

Most reported problems

Recent adverse event reports

The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.

• InjuryFeb 26, 2024Device Dislodged or Dislocated; Device Dislodged or Dislocated

  IT WAS REPORTED THAT THE PATIENT'S LEFT HIP WAS REVISED DUE TO DISLOCATION OF A COMPETITOR HEAD FROM A STRYKER CONSTRAINED INSERT. THE INSERT WAS REVISED TO AN ADM/ MDM POLY INSERT WITH MDM METAL LINER. REP CONFIRMED THAT NO FURTHER INFORMATION WILL BE RELEASED BY THE HOSPITAL OR SURGEON.

  Patient problems: Joint Dislocation

  MAUDE report 18784109 ↗
• InjuryDec 2, 2022Device Dislodged or Dislocated; Device Dislodged or Dislocated

  THE PATIENT SUFFERED A FRACTURE IN HIS RIGHT HIP IN 2012, AND HE UNDERWENT SURGERY WITH THE PLACEMENT OF A PROSTHESIS. HOWEVER, AROUND TWO YEARS LATER, IT WAS DIAGNOSED THAT THE PROSTHESIS WAS INFECTED WITH A FISTULA. A NEW SURGICAL PROCEDURE WAS PERFORMED TO REMOVE IT OF THE PROSTHESIS, PERFORMING SURGICAL DEBRIDEMENT AND PLACING A CEMENT SPACER WITH ANTIBIOTIC. IN A SECOND MOMENT, THE PATIENT UNDERWENT A NEW INTERVENTION TO REMOVE THE SPACER AND PLACE THE NEW PROSTHESIS, THE SURGERY BEING PERFORMED ON (B)(6)2014. AFTER SURGERY, WHEN PERFORMING A REVIEW CONSULTATION WITH THE PHYSICIAN, HE FOUND THROUGH AN EXAMINATION THAT THERE HAD BEEN DISLOCATION OF ARTHROPLASTY, THAT IS, DISPLACEMENT OF THE PROSTHETIC FEMORAL HEAD FROM ITS NORMAL PLACE WITH THE ACETABULAR COMPONENT. A NEW SURGICAL PROCEDURE WAS PERFORMED ON (B)(6) 2015 TO REMOVE THE PROSTHESIS. THE PATIENT ALLEGES A DEFECT IN THE ACETABULAR PROSTHESIS, WHICH ALLOWED THE DISPLACEMENT OF THE PROSTHETIC FEMORAL HEAD FROM ITS NORMAL PLACE. ADVERSE EVENTS REPORTED BY THE PATIENT: PAIN, INFECTION, SHORTENING OF THE RIGHT LEG, MOBILITY RESTRICTED TO WHEELCHAIR.

  Patient problems: Ambulation or Postural Difficulties; Pain; Unspecified Infection

  MAUDE report 15904373 ↗
• InjuryJun 21, 2021Detachment of Device or Device Component; Device Dislodged or Dislocated; Detachment of Device or Device Component; Device Dislodged or Dislocated

  THE PATIENT UNDERWENT SURGERY ON (B)(6) 2021 FOR THE PLACEMENT OF STRYKER PRODUCTS (TORX & TRIDENT). ON (B)(6) 2021, SHE WAS ADMITTED TO THE HOSPITAL FOR A DISLOCATION. WHEN PERFORMING X-RAY, SHE OBSERVED STRYKER PRODUCT FAILURE. THE PATIENT UNDERGOES URGENT REVISION SURGERY.

  Patient problems: Joint Dislocation

  MAUDE report 12030830 ↗